Groundbreaking

We are curious, fast and brave. We are scientific experts who want to improve the lives of patients. We rely on our outstanding scientific know-how, our leading antibody technology and novel therapeutic approaches to discover, develop and deliver transformative therapies for people who are impacted by cancer and autoimmune diseases.

Reliable

We are a reliable partner committed to the highest quality in everything we do. We provide top-quality products and services and are dedicated to excellence and safety in all processes of our value chain. We are fully aware that we bear a great responsibility.

Dedicated

We firmly believe that advanced antibody-based therapies are a key to treating cancer and autoimmune diseases. We love science, but even more so, we love helping patients who are impacted by these diseases. Every day we come to work driven to make a difference.

The patient in mind

Being able to help patients, give them hope and provide them with the best treatment available is our strongest motivation. Therefore, everything we do, every product, process, contact and service, needs to be of the highest quality to meet patients’ needs.

We are a commercial-stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for people living with cancer and autoimmune diseases. As of July 15, 2021, Constellation Pharmaceuticals is part of the MorphoSys Group. Together, we are committed to delivering breakthrough therapies that bring hope to life.


21/07/2021
Invitation to MorphoSys' Second Quarter and First Half 2021 Results...
16/07/2021
MorphoSys Concludes a US$ 100 Million Capital Increase to Implement the...
15/07/2021
MorphoSys to Complete Transformational Acquisition of Constellation...


MorphoSys
as a Partner

Visit

Company calendar

Date
Title
Add to Calendar
  1. 03/15/2021

    Year-End Results 2020

  2. 05/05/2021

    First Quarter Interim Statement 2021

  3. 05/19/2021

    Annual General Meeting 2021

  4. 07/28/2021

    Half-Year Report 2021

  5. 11/10/2021

    Third Quarter Interim Statement 2021

Upcoming conferences

Wed
28
'21
Jul

Half-Year Report 2021

Tue
31
'21
Aug

Commerzbank Corporate Conference 2021

virtual
Wed
22
'21
Sep

10th Baader Investment Conference

virtuell
Wed
10
'21
Nov

Third Quarter Interim Statement 2021


Stock information